Literature DB >> 16135948

Anthropometric characteristics and risk of multiple myeloma.

Cindy K Blair1, James R Cerhan, Aaron R Folsom, Julie A Ross.   

Abstract

BACKGROUND: Few studies have examined obesity and risk for multiple myeloma, and the results are inconsistent. Laboratory evidence suggests mechanisms through which obesity could influence carcinogenesis of this hematopoietic malignancy.
METHODS: We examined the association between anthropometric characteristics and incident multiple myeloma in a prospective, population-based sample of 37,083 postmenopausal women. In 1986, the women completed a mailed questionnaire that included self-report of height and weight, and friend measurement of waist and hip circumferences. During 16 years of follow up, 95 cases of multiple myeloma were identified through linkage to the Iowa Cancer Registry.
RESULTS: In an age-adjusted model, women in the highest category of several anthropometric measurements compared with the lowest category were at increased risk of developing multiple myeloma. For body mass index (kg/m), the rate ratio (95% confidence interval) was 1.5 (0.92-2.6); for weight, 1.9 (1.1-3.4); for waist circumference, 2.0 (1.1-3.5); and for hip circumference, 1.8 (1.0-3.0).
CONCLUSION: Greater adiposity may increase the risk of multiple myeloma.

Entities:  

Mesh:

Year:  2005        PMID: 16135948     DOI: 10.1097/01.ede.0000172135.61188.2d

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  22 in total

1.  Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women.

Authors:  Ola Landgren; S Vincent Rajkumar; Ruth M Pfeiffer; Robert A Kyle; Jerry A Katzmann; Angela Dispenzieri; Qiuyin Cai; Lynn R Goldin; Neil E Caporaso; Joseph F Fraumeni; William J Blot; Lisa B Signorello
Journal:  Blood       Date:  2010-04-26       Impact factor: 22.113

2.  High prevalence of polyclonal hypergamma-globulinemia in adult males in Ghana, Africa.

Authors:  Francis Buadi; Ann W Hsing; Jerry A Katzmann; Ruth M Pfeiffer; Adam Waxman; Edward D Yeboah; Richard B Biritwum; Yao Tettey; Andrew Adjei; Lisa W Chu; Angelo DeMarzo; George J Netto; Angela Dispenzieri; Robert A Kyle; S Vincent Rajkumar; Ola Landgren
Journal:  Am J Hematol       Date:  2011-06-14       Impact factor: 10.047

3.  Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey.

Authors:  O Landgren; B I Graubard; J A Katzmann; R A Kyle; I Ahmadizadeh; R Clark; S K Kumar; A Dispenzieri; A J Greenberg; T M Therneau; L J Melton; N Caporaso; N Korde; M Roschewski; R Costello; G M McQuillan; S V Rajkumar
Journal:  Leukemia       Date:  2014-01-20       Impact factor: 11.528

4.  Body size and multiple myeloma mortality: a pooled analysis of 20 prospective studies.

Authors:  Lauren R Teras; Cari M Kitahara; Brenda M Birmann; Patricia A Hartge; Sophia S Wang; Kim Robien; Alpa V Patel; Hans-Olov Adami; Elisabete Weiderpass; Graham G Giles; Pramil N Singh; Michael Alavanja; Laura E Beane Freeman; Leslie Bernstein; Julie E Buring; Graham A Colditz; Gary E Fraser; Susan M Gapstur; J Michael Gaziano; Edward Giovannucci; Jonathan N Hofmann; Martha S Linet; Gila Neta; Yikyung Park; Ulrike Peters; Philip S Rosenberg; Catherine Schairer; Howard D Sesso; Meir J Stampfer; Kala Visvanathan; Emily White; Alicja Wolk; Anne Zeleniuch-Jacquotte; Amy Berrington de González; Mark P Purdue
Journal:  Br J Haematol       Date:  2014-05-23       Impact factor: 6.998

5.  Body mass index and physical activity at different ages and risk of multiple myeloma in the NIH-AARP diet and health study.

Authors:  Jonathan N Hofmann; Steven C Moore; Unhee Lim; Yikyung Park; Dalsu Baris; Albert R Hollenbeck; Charles E Matthews; Todd M Gibson; Patricia Hartge; Mark P Purdue
Journal:  Am J Epidemiol       Date:  2013-03-29       Impact factor: 4.897

6.  Young Adult and Usual Adult Body Mass Index and Multiple Myeloma Risk: A Pooled Analysis in the International Multiple Myeloma Consortium (IMMC).

Authors:  Brenda M Birmann; Gabriella Andreotti; Anneclaire J De Roos; Nicola J Camp; Brian C H Chiu; John J Spinelli; Nikolaus Becker; Véronique Benhaim-Luzon; Parveen Bhatti; Paolo Boffetta; Paul Brennan; Elizabeth E Brown; Pierluigi Cocco; Laura Costas; Wendy Cozen; Silvia de Sanjosé; Lenka Foretová; Graham G Giles; Marc Maynadié; Kirsten Moysich; Alexandra Nieters; Anthony Staines; Guido Tricot; Dennis Weisenburger; Yawei Zhang; Dalsu Baris; Mark P Purdue
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-02-21       Impact factor: 4.254

7.  Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.

Authors:  P J Simpson-Haidaris; S J Pollock; S Ramon; N Guo; C F Woeller; S E Feldon; R P Phipps
Journal:  PPAR Res       Date:  2010-02-28       Impact factor: 4.964

8.  Abdominal adipose tissue in MGUS and multiple myeloma.

Authors:  Joyce Veld; Elizabeth K O'Donnell; Michaela R Reagan; Andrew J Yee; Martin Torriani; Clifford J Rosen; Miriam A Bredella
Journal:  Skeletal Radiol       Date:  2016-06-25       Impact factor: 2.199

9.  Insulin-like growth factor-1- and interleukin-6-related gene variation and risk of multiple myeloma.

Authors:  Brenda M Birmann; Rulla M Tamimi; Edward Giovannucci; Bernard Rosner; David J Hunter; Peter Kraft; Constantine Mitsiades; Kenneth C Anderson; Graham A Colditz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

10.  Body mass index, physical activity, and risk of multiple myeloma.

Authors:  Brenda M Birmann; Edward Giovannucci; Bernard Rosner; Kenneth C Anderson; Graham A Colditz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-07       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.